Raymond James Upgrades Humana to Outperform, Sets $520 Target
Raymond James raised Humana from Market Perform to Outperform and set a $520 per-share target, according to Dow Jones Newswires and Benzinga.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Raymond James upgraded Humana’s rating to Outperform from Market Perform on October 12, 2026. The firm announced a price target of $520.00 per share.
Dow Jones Newswires reported the action, citing Benzinga’s analyst-ratings data. The update was published at 11:36 GMT.
why it matters
The revised rating and price target may affect how investors assess Humana’s shares and could draw additional attention to the company’s stock.
instruments
sources
- Humana Price Target Announced at $520.00/Share by Raymond James — Dow Jones Newswires, 12 October 2026 at 11:36 UTC
- National Hlthcr Prop Price Target Announced at $20.00/Share by Raymond James — Newsmetry API, 13 October 2026 at 10:54 UTC
- American Healthcare REIT Price Target Announced at $62.00/Share by Raymond James — Newsmetry API, 13 October 2026 at 10:53 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗